ALK fusions have been identified in a variety of neoplasms, including inflammatory myofibroblastic tumor, many subtypes of lymphomas and leukemias, adenocarcinomas, benign fibrous histiocytoma, and several other tumors. The gene discussed is ALK; the disease is leukemia.